Plain-English translation of NCT07241533 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing asiaticoside, a natural compound extracted from centella asiatica, a traditional herb used in Asia for centuries. Researchers want to see if this medication can help adults who are overweight or have obesity lose weight and improve their overall health. Early laboratory studies suggest the treatment may reduce body fat and improve metabolism, but this study will be the first to test it safely in human patients.
Weight loss medications and treatments are limited, and many people struggle to find safe, effective options. This medication comes from a plant that has been used traditionally for health benefits, and laboratory studies show promise—so researchers want to see if it actually works in real patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will take tablets of the medication three times per day for 12 weeks (3 months). The study involves visits to Shanghai Zhongshan Hospital where researchers will check your weight, measure your body composition, and run blood tests to see how the treatment is working. You'll need to be able to commit to the full 12-week period and complete follow-up visits.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
China